TNNT1, a prognostic indicator in colon adenocarcinoma, regulates cell behaviors and mediates EMT process

References

• Forman D, Ferlay J. The global and regional burden of cancer. World cancer report. 2014;1:16–53.
   Google Scholar
• Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299:425–436.
   PubMed Web of Science ®Google Scholar
• Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis. 2011;29:222–228.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375:1030–1047.
   PubMed Web of Science ®Google Scholar
• Roncucci L, Mariani F. Prevention of colorectal cancer: how many tools do we have in our basket? Eur J Intern Med. 2015;26:752–756.
   PubMed Web of Science ®Google Scholar
• Neri E, Faggioni L, Cini L, et al. Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management. Cancer Manag Res. 2010;3:17–24.
   PubMedGoogle Scholar
• Tsukuda K, Tanino M, Soga H, et al. A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma. Biochem Biophys Res Commun. 2000;278:653–658.
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM. Targeted therapy in cancer. Cancer Chemother Pharmacol. 2015;76:1113–1132.
   PubMed Web of Science ®Google Scholar
• Herzig DO, Tsikitis VL. Molecular markers for colon diagnosis, prognosis and targeted therapy. J Surg Oncol. 2015;111:96–102.
   PubMed Web of Science ®Google Scholar
• Wei B, Jin JP. TNNT1, TNNT2, and TNNT3: isoform genes, regulation, and structure-function relationships. Gene. 2016;582:1–13.
   PubMed Web of Science ®Google Scholar
• Jin JP, Zhang Z, Bautista JA. Isoform diversity, regulation, and functional adaptation of troponin and calponin. Crit Rev Eukaryot Gene Expr. 2008;18:93–124.
   PubMed Web of Science ®Google Scholar
• Barton PJ, Townsend PJ, Brand NJ, et al. Localization of the fast skeletal muscle troponin I gene (TNNI2) to 11p15.5: genes for troponin I and T are organized in pairs. Ann Hum Genet. 1997;61:519–523.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhao Y, Zhang Y, et al. TNNT1 facilitates proliferation of breast cancer cells by promoting G1/S phase transition. Life Sci. 2018;208:161–166.
   PubMed Web of Science ®Google Scholar
• Ju Y, Li J, Xie C, et al. Troponin T3 expression in skeletal and smooth muscle is required for growth and postnatal survival: characterization of Tnnt3(tm2a(KOMP)Wtsi) mice. Genesis. 2013;51:667–675.
   PubMed Web of Science ®Google Scholar
• Petropoulou E, Soltani M, Firoozabadi AD, et al. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy. Eur J Med Genet. 2017;60:485–488.
   PubMed Web of Science ®Google Scholar
• Kawabe S, Mizutani T, Ishikane S, et al. Establishment and characterization of a novel orthotopic mouse model for human uterine sarcoma with different metastatic potentials. Cancer Lett. 2015;366:182–190.
   PubMed Web of Science ®Google Scholar
• Dean M. Cancer as a complex developmental disorder–nineteenth Cornelius P. Rhoads memorial award lecture. Cancer Res. 1998;58:5633–5636.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Li L, et al. Identification of molecular targets for predicting colon adenocarcinoma. Med Sci Monit. 2016;22:460–468.
   PubMed Web of Science ®Google Scholar
• Guay SP, Legare C, Brisson D, et al. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease. Epigenomics. 2016;8:359–371.
   PubMed Web of Science ®Google Scholar
• Abdulhaq UN, Daana M, Dor T, et al. Nemaline body myopathy caused by a novel mutation in troponin T1 (TNNT1). Muscle Nerve. 2016;53:564–569.
   PubMed Web of Science ®Google Scholar
• Lowe XR, Lu X, Marchetti F, et al. The expression of troponin T1 gene is induced by ketamine in adult mouse brain. Brain Res. 2007;1174:7–17.
   PubMed Web of Science ®Google Scholar
• Monteith GR, McAndrew D, Faddy HM, et al. Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer. 2007;7:519–530.
   PubMed Web of Science ®Google Scholar
• Kong D, Li Y, Wang Z, et al. Cancer stem cells and Epithelial-to-Mesenchymal Transition (EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel). 2011;3:716–729.
   PubMedGoogle Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196.
   PubMed Web of Science ®Google Scholar
• Sciacovelli M, Frezza C. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. FEBS J. 2017;284:3132–3144.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12:361–373.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–1428.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang G, Li X, et al. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor −1alpha in hepatocellular carcinoma. BMC Cancer. 2013;13:108.
   PubMed Web of Science ®Google Scholar